embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

2/18/25 5:00:00 PM ET

Medical/Dental Instruments

Health Care

Get the next $EMBC alert in real time by email

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ:EMBC) today announced that Jake Elguicze, embecta's Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET.

About embecta

embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts: 

Media

Christian Glazar

Sr. Director, Corporate Communications

908-821-6922

Contact Media Relations

Investors 

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547

Contact IR

Get the next $EMBC alert in real time by email

Date	Price Target	Rating	Analyst
4/10/2025	$15.00	Neutral	Mizuho
12/2/2024	$13.00 → $20.00	Underweight → Equal-Weight	Morgan Stanley
11/27/2024	$26.00	Neutral → Buy	BTIG Research
10/20/2023		Peer Perform	Wolfe Research
1/6/2023	$28.00	Equal-Weight → Underweight	Morgan Stanley
9/8/2022		Neutral	BTIG Research
8/1/2022	$33.00	Equal-Weight	Morgan Stanley
6/21/2022	$25.00	Underperform	BofA Securities

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

Chat with this insight

Recent Analyst Ratings for
$EMBC

$EMBC
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

Melcher David F bought $32,500 worth of shares (2,000 units at $16.25), increasing direct ownership by 5% to 45,080 units (SEC Form 4)

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

Chat with this insight

Recent Analyst Ratings for $EMBC

$EMBC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

Melcher David F bought $32,500 worth of shares (2,000 units at $16.25), increasing direct ownership by 5% to 45,080 units (SEC Form 4)

Recent Analyst Ratings for
$EMBC

$EMBC
Insider Purchases